I agree that this site is using cookies. You can find further informations here.
X
Chambers, Laura Moulton
93  results:
Search for persons X
?
1

Use of prophylactic closed incision negative pressure thera..:

Chambers, Laura Moulton ; Morton, Molly ; Lampert, Erika...
American Journal of Obstetrics and Gynecology.  223 (2020)  5 - p. 731.e1-731.e9 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Evaluation of non-completion of intraperitoneal chemotherap..:

Chambers, Laura Moulton ; Son, Ji ; Radeva, Milena.
Journal of Gynecologic Oncology.  30 (2019)  6 - p. , 2019
Link: https://doi.org/10.3802/..
 
?
3

Sentinel lymph node mapping in endometrial and cervical can..:

Chambers, Laura Moulton ; Vargas, Roberto ; Michener, Chad M.
Journal of Gynecologic Oncology.  30 (2019)  3 - p. , 2019
Link: https://doi.org/10.3802/..
 
?
4

Scalp application of antioxidants improves scalp condition ..:

Davis, Michael G. ; Piliang, Melissa P. ; Bergfeld, Wilma F....
International Journal of Cosmetic Science.  43 (2021)  S1 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
5

Scalp application of the antioxidant piroctone olamine redu..:

Davis, Michael G. ; Piliang, Melissa P. ; Bergfeld, Wilma F....
International Journal of Cosmetic Science.  43 (2021)  S1 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
6

Adjuvant treatment in high intermediate risk early stage en..:

Son, J. ; Carr, C. ; Chambers, L. Moulton...
Gynecologic Oncology.  156 (2020)  3 - p. e10 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Ethical authorship assignment gynecologic oncology: Keeping..:

Chambers, L. Moulton ; Watson, C.H. ; Buechel, M....
Gynecologic Oncology.  159 (2020)  - p. 283 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Hyperthermic intraperitoneal chemotherapy at the time of mi..:

Morton, M. ; Chichura, A.M. ; Chambers, L. Moulton...
Gynecologic Oncology.  159 (2020)  - p. 55 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Comparison of outcomes with utilization of hyperthermic int..:

Chambers, L. Moulton ; Horowitz, M.P. ; Costales, A.B....
Gynecologic Oncology.  159 (2020)  - p. 54-55 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Comparison of outcomes with utilization of hyperthermic int..:

Horowitz, M.P. ; Chambers, L. Moulton ; Gruner, M....
Gynecologic Oncology.  159 (2020)  - p. 54 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and toxicity of extended duration pegylated liposo..:

Chambers, L. Moulton ; Pendlebury, A.B. ; Yao, M...
Gynecologic Oncology.  159 (2020)  - p. 107-108 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Cisplatin chemotherapy impacts the gut microbiome in a prec..:

Chambers, L. Moulton ; Esakov, E.L. ; Braley, C....
Gynecologic Oncology.  159 (2020)  - p. 108 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Antibiotic use during chemotherapy negatively impacts outco..:

Chambers, L. Moulton ; Kuznicki, M. ; Chichura, A.M....
Gynecologic Oncology.  159 (2020)  - p. 116-117 , 2020
Link: https://doi.org/10.1016/..
 
?
14

The gut microbiome attenuates epithelial ovarian cancer gro..:

Chambers, L. Moulton ; Esakov, E.L. ; Braley, C....
Gynecologic Oncology.  159 (2020)  - p. 108-109 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Hyperthermic intraperitoneal chemotherapy (HIPEC) in epithe..:

Costales, A.B. ; Chambers, L. Moulton ; Chichura, A.M....
Gynecologic Oncology.  154 (2019)  - p. 257-258 , 2019
Link: https://doi.org/10.1016/..
 
1-15